Pharma-Bio Serv (PBSV) to Release Quarterly Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to be announcing its results before the market opens on Monday, March 16th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $2.70 million for the quarter.

Pharma-Bio Serv Price Performance

OTCMKTS PBSV opened at $0.49 on Monday. The stock’s 50 day simple moving average is $0.55 and its 200-day simple moving average is $0.57. The company has a market cap of $11.22 million, a PE ratio of -49.00 and a beta of 0.68. Pharma-Bio Serv has a 1-year low of $0.35 and a 1-year high of $1.36.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.